These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14967764)

  • 21. Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17?
    Zühlke C; Gehlken U; Hellenbroich Y; Schwinger E; Bürk K
    J Neurol; 2003 Feb; 250(2):161-3. PubMed ID: 12574945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically modified rodent models of SCA17.
    Cui Y; Yang S; Li XJ; Li S
    J Neurosci Res; 2017 Aug; 95(8):1540-1547. PubMed ID: 27859490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TATA-binding protein in neurodegenerative disease.
    van Roon-Mom WM; Reid SJ; Faull RL; Snell RG
    Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis.
    Mutesa L; Pierquin G; Segers K; Vanbellinghen JF; Gahimbare L; Bours V
    J Trop Pediatr; 2008 Oct; 54(5):350-2. PubMed ID: 18499737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with SCA17 featuring 41 CAG repeats presents with spastic paraplegia and involuntary movement.
    Ren Y; Zhang K; Zhang Q; Chen B; Niu S; Wang X; Zhang Z
    Parkinsonism Relat Disord; 2021 Aug; 89():87-89. PubMed ID: 34256333
    [No Abstract]   [Full Text] [Related]  

  • 26. Spinocerebellar ataxia type 7 mimicking Kearns-Sayre syndrome: a clinical diagnosis is desirable.
    Gupta SN; Marks HG
    J Neurol Sci; 2008 Jan; 264(1-2):173-6. PubMed ID: 17720198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile spinocerebellar ataxia type 6: relationship to episodic ataxia type 6.
    Gosalakkal JA; Swamy PM
    Pediatr Neurol; 2006 Apr; 34(4):301-2. PubMed ID: 16638506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of chromatin alterations in neurodegeneration induced by polyglutamine-expanded ataxin-7].
    Helmlinger D; Tora L; Devys D
    Med Sci (Paris); 2006; 22(8-9):700-2. PubMed ID: 16962040
    [No Abstract]   [Full Text] [Related]  

  • 29. Automated home cage assessment shows behavioral changes in a transgenic mouse model of spinocerebellar ataxia type 17.
    Portal E; Riess O; Nguyen HP
    Behav Brain Res; 2013 Aug; 250():157-65. PubMed ID: 23665119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17.
    Salvatore E; Varrone A; Sansone V; Nolano M; Bruni AC; De Rosa A; Santoro L; Pappatà S; Filla A; De Michele G
    Mov Disord; 2006 Jun; 21(6):872-5. PubMed ID: 16532453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinocerebellar ataxia type 2 in a Turkish family.
    Dirik E; Yiş U; Başak N; Soydan E; Hüdaoğlu O; Ozgönül F
    J Child Neurol; 2007 Jul; 22(7):891-4. PubMed ID: 17715286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats.
    Ansorge O; Giunti P; Michalik A; Van Broeckhoven C; Harding B; Wood N; Scaravilli F
    Ann Neurol; 2004 Sep; 56(3):448-52. PubMed ID: 15349877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinocerebellar ataxia type 2: progression before diagnosis.
    Klockgether T
    Lancet Neurol; 2014 May; 13(5):445-6. PubMed ID: 24657152
    [No Abstract]   [Full Text] [Related]  

  • 34. Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma.
    Doherty KM; Warner TT; Lees AJ
    Mov Disord; 2014 Jan; 29(1):36-8. PubMed ID: 24343983
    [No Abstract]   [Full Text] [Related]  

  • 35. Large Polyglutamine Repeats Cause Muscle Degeneration in SCA17 Mice.
    Huang S; Yang S; Guo J; Yan S; Gaertig MA; Li S; Li XJ
    Cell Rep; 2015 Oct; 13(1):196-208. PubMed ID: 26387956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predominant pathologic laughing and crying in a SCA17 patient.
    Lee HM; Pyo SJ; Kwon KY; Koh SB
    Parkinsonism Relat Disord; 2015 May; 21(5):547-8. PubMed ID: 25797299
    [No Abstract]   [Full Text] [Related]  

  • 37. Phenotype variability in spinocerebellar ataxia type 2: a longitudinal family survey and a case featuring an unusual benign course of disease.
    Hering S; Achmüller C; Köhler A; Poewe W; Schneider R; Boesch SM
    Mov Disord; 2009 Apr; 24(5):774-7. PubMed ID: 19224595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular investigation of TBP allele length: a SCA17 cellular model and population study.
    Reid SJ; Rees MI; van Roon-Mom WM; Jones AL; MacDonald ME; Sutherland G; During MJ; Faull RL; Owen MJ; Dragunow M; Snell RG
    Neurobiol Dis; 2003 Jun; 13(1):37-45. PubMed ID: 12758065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Senseless makes sense for spinocerebellar ataxia-1.
    Khurana V; Fulga TA; Feany MB
    Nat Neurosci; 2005 Nov; 8(11):1422-4. PubMed ID: 16251977
    [No Abstract]   [Full Text] [Related]  

  • 40. [Molecular analysis of the CAG repeat among patients with Type-2 spinocerebellar ataxia in the Mexican population].
    Magaña JJ; Vergara MD; Sierra-Martínez M; García-Jiménez E; Rodríguez-Antonio F; Gómez Mdel R; Valdés-Flores M; Cisneros B
    Gac Med Mex; 2008; 144(5):413-8. PubMed ID: 19043961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.